Health Canada Archives - Green Market Report

StaffJune 28, 2021
Canada3.jpg?fit=960%2C681&ssl=1

5min7680

Editors Note: This is a guest post. 

October 17, 2018, was the day when Canada approved recreational cannabis as per the Canada Act. But it saw a loss in the market value initially and was waiting eagerly for Cannabis 2.0. 

And guess what? The day arrived exactly one year later when Canada saw a second wave of cannabis legalization. This was the time when the country approved the sales of edibles, cannabis extracts, and topicals. And the market started cashing on this move. 

So what happened in the last two years, and what does the future of cannabis in Canada look like? Let’s find out!

Cannabis Sales Doubled in 2020

Quite evidently, Cannabis 2.0 propelled the industry towards growth. But that was not the only reason that led to the rise in popularity. The increased number of brick and mortar and click and collect offerings brought upon by expanding online cannabis space helped boost sales. 

But Cannabis 2.0 isn’t the only reason. Its increased acceptance and incredible therapeutic potential is making people buy weed online canada and propelling the industry to grow exponentially. Besides that, prompt adoption of new and latest methods amidst the pandemic made it an even more accessible and popular product across the country. 

In fact, the market is witnessing impressive growth in adult-use cannabis, with a growth of around 118% in 2020 compared to 60% in the year 2019. The diverse supply chain and the demanding customers are helping the growth of this industry every passing day. 

Enter 2021- What Changed?

The year started with so much promise for the cannabis industry. However, the sales dipped right at the beginning of the year. But as per the March sales figures, it set a record of 298.1 million Canadian dollars, rebounding from the decline that happened during the start of 2021. 

In fact, Canadian retail sales saw an increase of 13.8% in March compared to the last month. That’s looking bright, isn’t it?

What next?

Health Canada started an initiative to know what consumers feel about cannabis. By this, they meant what they think about selling, labeling, and researching cannabis. This feedback is prompting a mild relaxation of rules for packaging as well as possession of infused drinks. 

This consultation will impact the federal framework that will begin around the same time when the country will celebrate its third anniversary of cannabis legalization. Many cannabis experts think that Health Canada might change the equivalency rates for cannabis possession.

Other than that, there might be a change in the cannabis product labels. Currently, labels must display contents related to THC and CBD. But if the consumers want, Health Canada might ask to provide more information regarding the ingredients present in the product. 

The whole idea is to develop transparency in the cannabis market and help consumers find their suitable products easily and comfortably. 

Wrapping up

No one is expecting any sweeping changes this year. But the cannabis leaders want to clarify a few essential questions that are causing a stir in this industry related to advertising and celebrity endorsements. 

 

So, will it happen any time soon? Time will tell! For now, you can enjoy the vast array of cannabis products comfortably at your home, thanks to the incredible delivery services available now.


Debra BorchardtAugust 16, 2019
CannTrust3.png?fit=960%2C960&ssl=1

4min13800

The Ontario Securities Commission approved a request by CannTrust Holdings Inc. (NYSE: CTST) for a management cease trade order (“MCTO”) under National Policy 12-203 – Management Cease Trade Orders. Such a request means that the Chief Executive Officer, Chief Financial Officer and members of the board of directors or other persons who had or may have access to material information that has not been publicly disclosed can not trade shares of the company. CannTrust said that it does not affect the ability of investors who are not insiders to trade.

In addition to that, CannTrust said it will probably miss its filing deadline of August 14, 2019, to file an interim financial report for the three and six month periods ending June 30, 2019. CannTrust is now in a holding pattern waiting on decisions from Health Canada as a result of the company’s facilities not complying with the regulations as stated by law. “Health Canada has advised the Company that it is unable to provide any guidance about the timing or content of its decisions concerning the Company.”

Health Canada could order total destruction of the seized inventory, but so far hasn’t indicated if it will do so. CannTrust also said that has not had any discussions with Health Canada with regards fixing the situation it finds itself in.

NYSE

CannTrust is currently listed on the New York Stock Exchange and said it has kept the exchange up to date on its interactions with Health Canada. The company said in its statement that “The NYSE advised the Company that as a consequence of the Company’s announcements concerning its audited financial statements for the year ended December 31, 2018 and its unaudited financial statements for the quarter ended March 31, 2019, the Company is viewed as no longer having a complete annual report on Form 40-F on file for the year ended December 31, 2018.”

For now, CannTrust shares will continue to trade on both the Toronto Securities Exchange and the NYSE. “However, the NYSE advised the Company that (a) it will closely monitor the status of the Company’s late filing and any related public disclosures for up to six months from its due date, and (b) if the Company fails to file its annual report and any subsequent reports within six months of their filing due dates, the NYSE will determine, in its sole discretion, whether to halt trading in the Company’s securities or whether to allow the Company’s securities to trade for up to an additional six months, depending upon the circumstances.” The NYSE also noted that it could begin delisting the company shares at any time if the circumstances warranted it.

Financial Impact

At the beginning of the scandal, CannTrust repeatedly stated that it expected to take some sort of financial hit, but couldn’t determine what that would be. At this time, CannTrust says the estimated value of the inventory affected by the Health Canada decisions is roughly $51 million. This accounts for 53% of the total company inventory and about 30% of the total biological assets. CannTrust still has approximately $250 million in cash and cash equivalents.

 


Don't Miss This Week's Groundbreaking News

Join the thousands of subscribers who stay informed with GMR's exclusive news briefs delivered directly to your inbox every Friday afternoon.

We respect your privacy. See our privacy policy.


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 3 hours

⁦@BMO⁩ Outlines The Limits Of Limited License Markets $CRLBF $TCNNF

@GreenMarketRpt – 19 hours

Running a little late today but here’s your

@GreenMarketRpt – 1 day

Nevada schools have received $159 million from cannabis taxes in FY21. @ShopPlanet13…

Back to Top

Don't Miss This Week's Groundbreaking News

Join the thousands of subscribers who stay informed with GMR's exclusive news briefs delivered directly to your inbox every Friday afternoon.

We respect your privacy. See our privacy policy.